H. Sinzinger et al., ALTERATION OF RAT CEREBRAL MICROVASCULAR EICOSANOID FORMATION BY ISRADIPINE, A CALCIUM-CHANNEL BLOCKER, Prostaglandins, leukotrienes and essential fatty acids, 58(1), 1998, pp. 1-7
We studied the influence of the calcium channel blocker isradipine on
cerebral microvascular and aortic eicosanoid synthesis, The rat cerebr
al microvascular eicosanoid formation was assessed by means of bioassa
y, radioimmunoassay and radio thin layer chromatography from endogenou
s as well as from exogenous (20:4) radiolabelled substrate. The in vit
ro as well as the in vivo (0.3 mg/kg/day for 1 week) effect of isradip
ine was examined. Isradipine increased significantly (P < 0.01) both c
onversion to and formation of PGI(2) and its derivative 6-oxo-PGF(1 al
pha) respectively, as well as PGD(2)-production, while TXB2-synthesis
was diminished. The conversion to the other metabolites was not affect
ed to a significant extent. These findings indicate that isradipine en
hances PGI(2)-generation in aorta and cerebral microvessels from both
exogenous and endogenous substrate and PGD(2) from endogenous substrat
e, a phenomenon shown to underlie the antiatherosclerotic actions of t
his calcium channel blocker.